0001556754-14-000003.txt : 20141224 0001556754-14-000003.hdr.sgml : 20141224 20141224093856 ACCESSION NUMBER: 0001556754-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141224 DATE AS OF CHANGE: 20141224 EFFECTIVENESS DATE: 20141224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Novira Therapeutics, Inc. CENTRAL INDEX KEY: 0001556754 IRS NUMBER: 800335638 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-230841 FILM NUMBER: 141308940 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 215-260-7276 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 D 1 primary_doc.xml X0707 D LIVE 0001556754 Novira Therapeutics, Inc. 3805 OLD EASTON ROAD DOYLESTOWN PA PENNSYLVANIA 18902 215-260-7276 DELAWARE Molecmo Nanobiotechnologies Inc. None Corporation true Christian S. Schade c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Director Osvaldo Flores c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Douglas Carr c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Scott M. Rocklage c/o 5AM Ventures 2200 Sand Hill Road, Suite 110 Menlo Park CA CALIFORNIA 94025 Director Tim Shannon c/o Canaan Partners 285 Riverside Avenue, Suite 250 Westport CT CONNECTICUT 06880 Director Gianni Gromo c/o Versant Ventures One Sansome Street, Suite 3630 San Francisco CA CALIFORNIA 94104 Director Anthony Ford-Hutchinson c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Director Nathaniel Brown c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer George Hartman c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Klaus Klumpp c/o Novira Therapeutics, Inc. 3805 Old Easton Road Doylestown PA PENNSYLVANIA 18902 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2014-12-12 false true true true false 0 9000000 9000000 0 Does not include purchase price in the aggregate amount of $90.00 paid for warrants issued in transaction. false 10 0 0 1300000 true false Novira Therapeutics, Inc. Douglas Carr Douglas Carr Vice President of Finance, Secretary & Treasurer 2014-12-22